77 completed, 13 unknown, 9 terminated, 7 recruiting. 39 Phase 2, 25 Phase 1, 21 Not applicable, 20 Phase 3, 18 Phase 4.
Follow Ointments: new trials by email Literature Review of Ointments trials Research Report on Ointments
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical and Radiographic Success of Calcium Hydroxide-Iodoform Paste Versus Modified Triple Antibiotic Paste for Necrotic Primary Molars in Children Calcium Hydroxide, Iodoform, paste, modified triple antibiotic paste - Dental Pulp Necrosis, Periapical Diseases | Not applicable | Not yet recruiting | Cairo University | 50 | 2027-01-01 | 2026-08-19 |
| Efficacy of Fractional Co2 Laser With Topical Tacrolimus 0.1 in the Treatment of Nail Psoriasis fractional C02 laser, Topical tacrolimus 0.1% ointment - Nail Psoriasis | Not applicable | Not yet recruiting | Cairo University | 29 | 2026-11-01 | 2026-11-05 |
| Efficacy of Crisaborole 2% Ointment Versus Tacrolimus 0.1% Ointment in the Treatment of Intertriginous and/or Anogenital Psoriasis. Crisaborole 2% topical ointment, tacrolimus ointment 0.1% - Psoriasis, Psoriasis Genital | Phase 3 | Not yet recruiting | Cairo University | 40 | 2026-10-25 | 2026-10-27 |
| A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo MH004 1.0% Ointment, MH004 Placebo Ointment - Vitiligo | Phase 3 | Recruiting | Minghui Pharmaceutical (Hangzhou) Ltd | 405 | 2026-08-04 | 2026-08-11 |
| Topical Ruxolitinib Versus Tacrolimus With Excimer Laser for Localized Vitiligo Tacrolimus 0.1% ointment, Ruxolitinib 1.5% cream, 308-nm excimer laser - Vitiligo, Nonsegmental Vitiligo | Not applicable | Enrolling by invitation | Kafrelsheikh University | 40 | 2026-07-01 | 2026-11-02 |
| New Topical Treatment in Patchy Alopecia Areata topical metformin 30% ointment, Topical Simvastatin 2% ointment, Topical betamethasone valerate 0.1% ointment - Alopecia Areata | Not applicable | Not yet recruiting | Sohag University | 60 | 2026-06-28 | 2026-07-10 |
| Topical Nitroglycerin Versus Lateral Internal Sphincterotomy for Chronic Anal Fissure Topical 0.2% Glyceryl Trinitrate (Nitroglycerin) Ointment, Lateral Internal Sphincterotomy - Chronic Anal Fissure | Not applicable | Completed | Sheikh Zayed Federal Postgraduate Medical Institute | 72 | 2026-06-15 | 2026-10-21 |
| Topical Corticosteroid and Wound Healing After Periodontal Flap Surgery Triamcinolone Acetonide 0.1% Oral Paste, Open Flap Debridement - Periodontitis | Not applicable | Recruiting | Kahramanmaras Sutcu Imam University | 40 | 2026-06-01 | 2026-11-13 |
| Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer Light in the Treatment of Stable Non-segmental Facial Vitiligo: a Prospective Randomized Controlled Study. Crisaborole 2% topical ointment, tacrolimus 0.1%, Excimer Light therapy - Vitiligo, Non-Segmental Vitiligo (NSV) | Phase 3 | Recruiting | Cairo University | 35 | 2026-05-15 | 2026-10-29 |
| Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis. Acupuncture, Calcipotriol 0.005% ointment, Chinese herb cream - Plaque Type Psorisis | Phase 2 | Recruiting | Mae Fah Luang University | 28 | 2026-02-09 | 2026-02-13 |
| A Real-World Study on Effect of Hirudoid on Ecchymosis After Treatment of Crow's Feet With Botulinum Toxin Type A Hirudoid (heparinoids) ointment, 3mg/g - Ecchymosis After Periorbital Rejuvenation With Botulinum Toxin Type A, Crow's Feet Lines | Phase 4 | Not yet recruiting | DKSH Management (Thailand) Limited | 48 | 2026-02-01 | 2026-02-05 |
| Sore Throat After Open Neck Elective Surgery Hydrocortisone Acetate 1% Ointment, Lidocaine hydrochloride 0,05% with chlorhexidine - Postoperative Sore Throat, Cough, Hoarseness, Thyroid and Parathyroid Surgery | Phase 4 | Recruiting | Saint Petersburg State University, Russia | 764 | 2025-09-15 | 2026-04-13 |
| Garlic Oil As Root Filling Material in Primary Molars Garlic oil, Calcium Hydroxide, Iodoform, paste - Irreversible Pulpitis (toothache) | Not applicable | Not yet recruiting | Cairo University | 40 | 2025-08-08 | 2025-03-20 |
| Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo Narrowband UVB Phototherapy, Topical Tacrolimus 0.1% ointment, Topical Tyrosine 2% cream - Vitiligo | Not applicable | Completed | Minia University | 67 | 2025-08-01 | 2026-10-08 |
| Effect of Zinc Oxide Ointment on Recurrent Aphthous Stomatitis zinc oxide, Placabo - Recurrent Aphthous Stomatitis | Phase 4 | Completed | Faculty of Dental Medicine for Girls | 100 | 2025-06-30 | 2026-05-04 |
| Treatment Outcomes and Patient Satisfaction of Oral Lichen Planus Treatment Honey in orabase 1: 1 paste - Erosive Oral Lichen Planus, Atrophic Lichen Planus | Phase 2 | Completed | Dar Al Uloom University | 56 | 2025-05-20 | 2026-08-27 |
| Efficacy and Safety of GTN vs. Nifedipine in Acute Anal Fissure: A Clinical Trial Glyceryl Trinitrate (GTN) 0.2% Ointment, Glyceryl Trinitrate (GTN) 0.4% Ointment, Nifedipine 0.2% Ointment - Acute Anal Fissure, Anal Pain | Phase 4 | Completed | Hafiz Muhammad Hamza | 110 | 2025-03-17 | 2025-05-14 |
| Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis Topical treatment - Actinic Keratosis of Face and Scalp | Phase 3 | Recruiting | Aresus Pharma GmbH | 280 | 2024-09-04 | 2025-08-22 |
| A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH Active comparator, Experimental group, Combination of laser and paste - Dentin Sensitivity, Hypersensitivity | Not applicable | Unknown | Dow University of Health Sciences | 120 | 2024-05-12 | 2024-07-26 |
| The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus Triamcinolone Acetonide 0.1% Oint, Tacrollimus Topical, Selenium - Lichen Planus, Oral | Phase 4 | Completed | Al-Azhar University | 50 | 2024-05-01 | 2025-12-31 |
Showing 20 of 118. Sign in to see all of them.
Dermatitis, Atopic (14) · Psoriasis (9) · Vitiligo (7) · Keratosis, Actinic (5) · Vulvar Lichen Sclerosus (4) · Alopecia Areata (3) · Eczema (3) · Epidermolysis Bullosa Simplex (3) · Pain, Postoperative (3) · Dental Pulp Necrosis (2) · Dermatitis (2) · Epidermolysis Bullosa (2) · Fissure in Ano (2) · Impetigo (2) · Lymphoma, T-Cell, Cutaneous (2)
LEO Pharma (8) · Castle Creek Pharmaceuticals, LLC (7) · Cairo University (5) · Dermavant Sciences GmbH (3) · Actavis Inc. (2) · Almirall, S.A. (2) · Bayer (2) · DFB Soria, LLC (2) · Galderma R&D (2) · Medstar Health Research Institute (2) · Minghui Pharmaceutical (Hangzhou) Ltd (2) · Pfizer (2) · Sohag University (2) · Ajou University School of Medicine (1) · Al-Azhar University (1)
United States (45) · Egypt (11) · Germany (11) · France (5) · Canada (4) · China (4) · South Korea (4) · Spain (4) · Italy (3) · Pakistan (3) · Turkey (Türkiye) (3) · United Kingdom (3) · Denmark (2) · Finland (2) · Israel (2)
Mary Spellman, MD (6) · James Lee, MD, PhD (3) · Catherine Queille-Roussel, MD (2) · Gary Goldenberg, MD (2) · Paul A. Lehman,, M.Sc. (2) · Albert C. Yan, MD (1) · Albert Y Wu, M.D., Ph.D. (1) · Alberto Lecchi (1) · Almostafa M Ahmed (1) · Angus Gidely-Baird, PhD (1) · Antonio Arroyo, PhD (1) · Arda Isik (1) · Brian Poligone, MD, PhD (1)
PMID 16612915, PMID 16680006, PMID 18385500, PMID 20070141, PMID 21039597, PMID 22805051, PMID 22810476, PMID 22920495, PMID 22951056, PMID 23374261, PMID 23388687, PMID 23652752, PMID 24284985, PMID 24742019, PMID 25053981, PMID 25607709, PMID 25708531, PMID 26041481, PMID 26297574, PMID 27869649, PMID 28598453, PMID 29338124, PMID 30365584, PMID 31564933, PMID 32785881, PMID 33088056, PMID 33957642, PMID 35122614, PMID 35471470, PMID 36762782, PMID 37145134, PMID 37546514, PMID 38054133, PMID 38508975, PMID 38616424, PMID 39878173, PMID 39998969, PMID 40036375, PMID 41091393, PMID 41566030, PMID 41628614, PMID 41789288, PMID 42384057, PMID 7907336
2017 (2), 2019 (1)